Pharmaceutical Contract Manufacturing 2016 Global Market Expected to Grow at CAGR 6.91% and Forecast to 2020

Pune India, November 14, 2016 /MarketersMEDIA/ --
The analysts forecast the global pharmaceutical contract manufacturing market to grow at a CAGR of 6.91% during the period 2016-2020.

Contract manufacturing involves outsourcing manufacturing products to organizations, which helps the organizations offer the same services at a relatively lower cost. Typically, in the pharmaceutical and biotechnology sectors, the sourcing companies seek contract manufacturing services to restructure their resource deployment toward high skill areas such as R&D and marketing. Contract manufacturing has potential growth opportunities in emerging countries such as India and China.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/742758-global-pharmaceutical-contract-manufacturing-market-2016-2020

For more information or any query mail at [email protected]

Covered in this report

The report covers the present scenario and the growth prospects of the global pharmaceutical contract manufacturing market for 2016-2020. To calculate the market size, the report considers the revenue generated from various pharmaceutical drug manufacturing outsourcing activities.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

The report, Global Pharmaceutical Contract Manufacturing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Catalent
• Lonza
• Pfizer CentreOne

Complete Report Details @ https://www.wiseguyreports.com/reports/742758-global-pharmaceutical-contract-manufacturing-market-2016-2020

Other prominent vendors
• Abbott
• Aenova
• Amgen
• Apotex
• Aspen
• AstraZeneca
• Aurobindo Pharma
• Baxter
• BERLIN-CHEMIE
• Biocon
• Biogen
• Boehringer Ingelheim
• Celltrion
• Cipla
• Coherus Biosciences
• Daiichi Sankyo
• Dr. Reddy's Laboratories
• Eli Lilly
• Emcure Pharmaceuticals
• Eurofarma Laboratories
• Fareva
• Gedeon Richter
• Gilead Sciences
• GlaxoSmithKline (GSK)
• Hospira
• Impax Laboratories
• Intas Pharmaceuticals
• Janssen Pharmaceuticals
• Lupin
• Merck
• Mitsubishi Tanabe Pharma
• Momenta Pharmaceuticals
• Natco Pharma
• Nexus Pharmaceuticals
• Novo Nordisk
• Orchid Chemicals & Pharmaceuticals
• Par Pharmaceutical
• Parenteral Drugs India
• Patheon
• Piramal
• Roche Holding
• Sanofi
• Synthon
• Teva Pharmaceuticals
• Valeant Pharmaceuticals
• Zentiva
• Zhejiang Huahai Pharmaceutical
• Zydus Cadila

Market driver
• High number of US FDA-approved manufacturing facilities in emerging countries.
• For a full, detailed list, view our report

Market challenge
• Capacity utilization issues and lack of information integration.
• For a full, detailed list, view our report

Market trend
• Huge demand for next-generation biologics.
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Table Of Contents – Major Key Points

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Pharmaceutical manufacturing outsourcing
• Increased regulatory guidelines coupled with healthcare cost containment efforts
• Rapid innovation and reduced product development lifecycle
• High capital investment

PART 06: Market landscape
• Market overview
• Five forces analysis

PART 07: Market segmentation by type of contract manufacturing
• Global API/bulk drug contract manufacturing market
• Global FDF market

PART 08: Geographical segmentation
• Global pharmaceutical contract manufacturing market by geography
• Pharmaceutical contract manufacturing market in Americas
• Pharmaceutical contract manufacturing market in APAC
• Pharmaceutical contract manufacturing market in EMEA

PART 09: Key leading countries

PART 10: Market drivers
• Increased focus on core competence
• High number of US FDA-approved manufacturing facilities in emerging countries
• Shorter time-to-market

..……CONTINUED

For more information or any query mail at [email protected]

Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=742758

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuy Research Consultants Pvt Ltd.
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028
Phone: +1-646-845-9349
Website: https://www.wiseguyreports.com

Release ID: 145806